A recent study has revealed that DExD-box helicase 39B (DDX39B) promotes the stabilization of the SREBP1 protein by inhibiting the FBXW7-mediated ubiquitination and degradation of SREBP1, suggesting that DDX39B is a novel therapeutic target in HCC [117]. This evidence concerns the gene DDX39B and hepatocellular carcinoma.